Skip to main content

Original Research

Original Research, Practice Management
Comparing Treatment Persistence, Healthcare Resource Utilization, and Costs in Adult Patients with Major Depressive Disorder Treated with Escitalopram or Citalopram
Eric Q. Wu, PhD, Paul E. Greenberg, MA, Rym Ben-Hamadi, MSc, Andrew P. Yu, PhD, Elaine H. Yang, PhD, M. Haim Erder, PhD
Stakeholder Perspective
Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
When Information Is Insufficient: Inspiring Patients for Medication Adherence and the Role of Social Support Networking
Maureen Hennessey, PhD, CPCC, John W. Heryer, MD, FACS
Stakeholder Perspective
Health Plans Must “COPE” with Chronic Diseases
by Gary M. Owens, MD
Read More
Original Research, Practice Management
Addressing Costs and Continuity of Care through Innovative Solutions for Infused Therapies: A Collaborative Experience with Infliximab
Rhett Johnson, MA, Edward N. Freeman, FACMPE, MBA
Stakeholder Perspective
New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies
by Richard F Radzin, PharmD
Read More
Original Research
Engaging Providers in Medication Adherence: A Health Plan Case Study
Amy B. Scott, BSPharm, RPh, Jane E. McClure, BA, RN, F. Randy Vogenberg, PhD, FASHP
Stakeholder Perspective
Stakeholder Integration Crucial to Improved Patient Outcomes: Lessons from a Health Plan’s Experience
Read More
Original Research, Practice Management
The H-E-B Value-Based Health Management Program: Impact on Asthma Medication Adherence and Healthcare Cost
Anna O. D’Souza, PhD, Beth Common, MBA, Roshan Rahnama, MPH, Steven Burch, PhD, Timothy S. Regan, BPharm, RPh
Stakeholder Perspective
Value-Based Insurance Design: Evolving Strategies to Improve Medication Adherence, Control Healthcare Utilization
by Richard F Radzin, PharmD
Read More
Original Research
Managing Dyslipidemia in Primary Care with Restricted Access to Lipid-Modifying Therapy
John T. Lynch, MPH, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Jonathan Rosen, MD, Sanjay Gandhi, PhD, Michael F. Bullano, PharmD
Stakeholder Perspective
Appropriate Medication Selection Key to Cost-Effective Therapy, Patient Adherence
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study
Anna D’Souza, PhD, Brian L. Meissner, PharmD, PhD, Boxiong Tang, MD, PhD, Scott McKenzie, MD, Catherine T. Piech, MBA
Stakeholder Perspective
Effectiveness of Anti-TNFs in Patients with RA, and Coverage Considerations
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Meta-Analysis 101: What You Want to Know in the Era of Comparative Effectiveness
J. B. Jones, PhD, MBA, Saul Blecker, MD, Nirav R. Shah, MD,MPH
Stakeholder Perspective
Meta-Analyses and Patient Care
by Scott R. Taylor, RPh, MBA
Read More
Original Research
Depression Overview
Thomas McCarter, MD, FACP
Read More
Original Research
Schizophrenia: Current Concepts and Approaches to Patient Care
Peter F. Buckley, MD, Adriana Foster, MD
Stakeholder Perspective
The Approach to Schizophrenia
by Michael Schaffer, PharmD
Read More
Page 19 of 21
Results 181 - 190 of 209